As proof-of-concept, we show that an antibody-drug conjugate (ADC) of 33B7 conjugated with saporin was effective in inhibiting in vitro cell proliferation and in vivo tumor growth of PTGFRN-positive cancer cells A431 and AGSCC-3 cells. Here, PTGFRN is linked to neoplasm.